Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Part of paid clinical trials in Coral Gables, Florida.

Sponsor
Montefiore Medical Center
Study ID
NCT06181994
Status
Recruiting
Apply to this trial

Conditions

  • Chronic Subdural Hematoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

Key Dates

First listed
Dec 26, 2023
Start date
Dec 5, 2023
Status verified
Sep 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: MMA Embolization
    Adults with chronic subdural hematoma who underwent endovascular embolization of the middle meningeal artery as part of routine clinical care, using any embolic material
  • Arm: Surgical Evacuation
    Adults with chronic subdural hematoma who underwent surgical drainage of the hematoma as part of routine clinical care.
  • Arm: Observation only
    Adults with chronic subdural hematoma who were managed with clinical and imaging monitoring, without embolization or surgery.

Primary Outcome Measure

Reaccumulation of Hematoma [ Time Frame: Within 1 month post MMAE ]

Central Contacts

Locations (18)

FacilityCityStateZIPSite coordinators
Baptist Health South Florida, Inc.Coral GablesFlorida33143
Italo Linfante, MD
[email protected]
786-596-1825
Mayo Clinic FloridaJacksonvilleFlorida32224-
University of MiamiMiamiFlorida33136
Robert Starke, MD
[email protected]
305-243-3254
Orlando Regional Medical CenterOrlandoFlorida32806
Paul Foreman, MD
[email protected]
321-841-7550
University of Chicago MedicineChicagoIllinois60637
Tareq Kass-Hout, MD
[email protected]
773-702-6222
University of Illinois ChicagoChicagoIllinois60607-
The University of IowaIowa CityIowa52242-
Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical SchoolBostonMassachusetts02215
Christopher S Ogilvy, MD
[email protected]
617-632-7246
Massachusetts General HospitalBostonMassachusetts02114
Aman Patel, MD
[email protected]
617-643-5547
Lahey Hospital and Medical CenterBurlingtonMassachusetts01805
Timo Krings, MD, PhD, MSc
[email protected]
781-744-3330
Allina HealthMinneapolisMinnesota55404
Collin M Torok, MD
[email protected]
612-863-0376
Marie Meyer, MA
[email protected]
Mayo ClinicRochesterMinnesota55905-
Montefiore Medical CenterThe BronxNew York10467
Muhammed Amir Essibayi, MD
[email protected]
347-908-1889
David Altschul, MD
[email protected]
718-920-7498
Geisinger HealthDanvillePennsylvania17822-
Thomas Jefferson UniversityPhiladelphiaPennsylvania19144
Pascal M Jabbour, MD
[email protected]
215-955-7000
UTHealth HoustonHoustonTexas77030-
HCA Houston Healthcare KingwoodKingwoodTexas77339-
West Virginia UniversityMorgantownWest Virginia26506
Dhairya A Lakhani, MD
[email protected]
304-293-9198
Tyler McGaughey, PhD
[email protected]

Find similar trials in Coral Gables, FL

By research site
Baptist Health South Florida, Inc.· Coral Gables, FLMayo Clinic Florida· Jacksonville, FLUniversity of Miami· Miami, FLOrlando Regional Medical Center· Orlando, FLUniversity of Chicago Medicine· Chicago, ILUniversity of Illinois Chicago· Chicago, IL

Related Studies